Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
capsids
Biotech
Novartis ignites new stage of Voyager pact with $15M capsid deal
Novartis is paying Voyager $15 million to take up its option on a novel capsid for use in a rare neurological disease gene therapy program.
Nick Paul Taylor
Sep 5, 2024 9:45am
Novartis ready to head for deep space with Voyager
Mar 6, 2023 7:00am
Neurocrine blows fresh wind in Voyager's sails with $175M payday
Jan 9, 2023 9:30am
Lilly pays $55M to join AbbVie on AAV specialist's partner list
Jan 4, 2023 7:45am
Pfizer pulls trigger on Voyager gene therapy capsid deal
Oct 4, 2022 9:46am
